Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albany Molecular Research Inc (NASDAQ:AMRI)

13.72
Delayed Data
As of Jul 26
 -0.08 / -0.58%
Today’s Change
12.45
Today|||52-Week Range
22.48
-30.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line-3.8M12.7M-3.3M-2.3M
 
 
 
 
 
Depreciation17.3M15.9M18.4M27.0M
 
 
 
 
 
Total Other Cash Flow10.6M4.7M17.6M18.4M
 
 
 
 
 
Funds From Operations27.5M33.4M30.5M40.2M
 
 
 
 
 
Funds From/For Other Operating Expenses12.2M5.2M28.6M599.0K
 
 
 
 
 
Net Cash Flow - Operating Activities15.3M28.2M1.9M39.6M
 
 
 
 
 
 
InvestingDecrease In Investments213.0K0.000.000.00
 
 
Capital Expenditures-9.9M-11.1M-17.2M-22.0M
 
 
 
 
 
Fixed Asset Disposal447.0K300.0K80.0K31.0K
 
 
 
 
 
Net Assets From Acquisitions 0.000.00-145.8M-199.6M
 
 
 
Net Cash Flow Investing-9.8M-11.2M-163.3M-221.7M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings5.0M145.3M34.5M261.5M
 
 
 
 
 
Long Term Debt Reduction-2.8M-775.0K-5.1M-81.9M
 
 
 
 
 
Net Proceeds Stock Sale0.0023.1M0.000.00
 
 
Common Preferred Redeemed0.00-164.0K-579.0K-824.0K
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing531.0K3.0M4.4M5.6M
 
 
 
 
 
Other Uses - Financing5.2M33.6M0.000.00
 
 
 
Net Cash Flow - Financing-2.5M136.9M33.2M184.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash288.0K-1.2M-820.0K-980.0K
 
 
 
 
 
 
Net Change In Cash3.0M153.8M-128.1M2.2M